Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Teladoc Health Inc has a consensus price target of $18.78 based on the ratings of 33 analysts. The high is $40 issued by DA Davidson on October 25, 2022. The low is $8 issued by TD Cowen on October 31, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Piper Sandler, and Goldman Sachs on March 3, 2025, February 27, 2025, and February 18, 2025, respectively. With an average price target of $13.67 between Goldman Sachs, Piper Sandler, and Goldman Sachs, there's an implied 60.78% upside for Teladoc Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/03/2025 | Buy Now | 52.94% | Goldman Sachs | David Roman37% | $16 → $13 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | — | Needham | Ryan MacDonald60% | — | Reiterates | Hold → Hold | Get Alert |
02/27/2025 | Buy Now | 41.18% | Piper Sandler | Jessica Tassan40% | $13 → $12 | Maintains | Overweight | Get Alert |
02/18/2025 | Buy Now | 88.24% | Goldman Sachs | David Roman37% | $14 → $16 | Maintains | Buy | Get Alert |
02/12/2025 | Buy Now | 58.82% | B of A Securities | Allen Lutz59% | $11.5 → $13.5 | Maintains | Neutral | Get Alert |
02/06/2025 | Buy Now | 35.29% | B of A Securities | Allen Lutz59% | $10.5 → $11.5 | Maintains | Neutral | Get Alert |
01/24/2025 | Buy Now | 41.18% | RBC Capital | Sean Dodge48% | $11 → $12 | Maintains | Outperform | Get Alert |
01/24/2025 | Buy Now | 41.18% | Oppenheimer | Michael Wiederhorn61% | $14 → $12 | Maintains | Outperform | Get Alert |
12/04/2024 | Buy Now | 52.94% | Piper Sandler | Jessica Tassan40% | $11 → $13 | Reiterates | Overweight → Overweight | Get Alert |
11/15/2024 | Buy Now | 64.71% | Goldman Sachs | David Roman37% | → $14 | Initiates | → Buy | Get Alert |
11/01/2024 | Buy Now | 41.18% | Deutsche Bank | George Hill62% | $10 → $12 | Maintains | Hold | Get Alert |
10/31/2024 | Buy Now | 41.18% | Barclays | Steve Valiquette53% | $10 → $12 | Maintains | Overweight | Get Alert |
10/31/2024 | Buy Now | -5.88% | TD Cowen | Charles Rhyee37% | $9 → $8 | Maintains | Hold | Get Alert |
10/09/2024 | Buy Now | 17.65% | RBC Capital | Sean Dodge48% | $9 → $10 | Maintains | Outperform | Get Alert |
10/08/2024 | Buy Now | 5.88% | Evercore ISI Group | Elizabeth Anderson47% | $8 → $9 | Maintains | In-Line | Get Alert |
09/17/2024 | Buy Now | 17.65% | Jefferies | Glen Santangelo50% | $8 → $10 | Maintains | Hold | Get Alert |
08/26/2024 | Buy Now | 5.88% | JP Morgan | Lisa Gill59% | $16 → $9 | Maintains | Neutral | Get Alert |
08/20/2024 | Buy Now | 17.65% | Cantor Fitzgerald | Sarah James51% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
08/06/2024 | Buy Now | 17.65% | Piper Sandler | Jessica Tassan40% | $25 → $10 | Maintains | Overweight | Get Alert |
08/02/2024 | Buy Now | 17.65% | Deutsche Bank | George Hill62% | $15 → $10 | Maintains | Hold | Get Alert |
08/02/2024 | Buy Now | 17.65% | Truist Securities | Jailendra Singh38% | $15 → $10 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | — | Needham | Ryan MacDonald60% | — | Reiterates | → Hold | Get Alert |
08/01/2024 | Buy Now | 5.88% | TD Cowen | Charles Rhyee37% | $15 → $9 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | 5.88% | RBC Capital | Sean Dodge48% | $18 → $9 | Maintains | Outperform | Get Alert |
08/01/2024 | Buy Now | 17.65% | Barclays | Steve Valiquette53% | $20 → $10 | Maintains | Overweight | Get Alert |
08/01/2024 | Buy Now | 5.88% | Stifel | David Grossman63% | $16 → $9 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | -5.88% | DA Davidson | Gil Luria59% | $12 → $8 | Maintains | Neutral | Get Alert |
08/01/2024 | Buy Now | 100% | Canaccord Genuity | Richard Close47% | $25 → $17 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | 100% | Oppenheimer | Michael Wiederhorn61% | $21 → $17 | Maintains | Outperform | Get Alert |
07/09/2024 | Buy Now | 17.65% | Evercore ISI Group | Elizabeth Anderson47% | $14 → $10 | Maintains | In-Line | Get Alert |
05/21/2024 | Buy Now | 88.24% | JP Morgan | Lisa Gill59% | $19 → $16 | Maintains | Neutral | Get Alert |
05/20/2024 | Buy Now | 64.71% | Jefferies | Glen Santangelo50% | $16 → $14 | Maintains | Hold | Get Alert |
05/14/2024 | Buy Now | 58.82% | B of A Securities | Allen Lutz59% | $16.5 → $13.5 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | 76.47% | Wells Fargo | Stephen Baxter54% | $17 → $15 | Maintains | Equal-Weight | Get Alert |
04/26/2024 | Buy Now | 147.06% | Oppenheimer | Michael Wiederhorn61% | $26 → $21 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | 76.47% | TD Cowen | Charles Rhyee37% | $16 → $15 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 64.71% | Evercore ISI Group | — | $15 → $14 | Maintains | In-Line | Get Alert |
04/26/2024 | Buy Now | 111.76% | RBC Capital | Sean Dodge48% | $25 → $18 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | 88.24% | Stifel | David Grossman63% | $21 → $16 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 135.29% | Barclays | Steve Valiquette53% | $25 → $20 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 194.12% | Canaccord Genuity | Richard Close47% | $28 → $25 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | — | Needham | Ryan MacDonald60% | — | Reiterates | → Hold | Get Alert |
04/05/2024 | Buy Now | — | Needham | Ryan MacDonald60% | — | Reiterates | → Hold | Get Alert |
03/06/2024 | Buy Now | 100% | Truist Securities | Jailendra Singh38% | $23 → $17 | Maintains | Hold | Get Alert |
02/29/2024 | Buy Now | 158.82% | Cantor Fitzgerald | Sarah James51% | → $22 | Initiates | → Overweight | Get Alert |
02/26/2024 | Buy Now | 100% | Leerink Partners | Michael Cherny79% | → $17 | Initiates | → Market Perform | Get Alert |
02/21/2024 | Buy Now | 111.76% | DA Davidson | Gil Luria59% | $22 → $18 | Maintains | Neutral | Get Alert |
02/21/2024 | Buy Now | 123.53% | Citigroup | Daniel Grosslight42% | $21 → $19 | Maintains | Neutral | Get Alert |
02/21/2024 | Buy Now | 194.12% | RBC Capital | Sean Dodge48% | $30 → $25 | Maintains | Outperform | Get Alert |
02/21/2024 | Buy Now | 194.12% | Barclays | Steve Valiquette53% | $26 → $25 | Maintains | Overweight | Get Alert |
02/21/2024 | Buy Now | 194.12% | Piper Sandler | Jessica Tassan40% | $30 → $25 | Maintains | Overweight | Get Alert |
02/21/2024 | Buy Now | 229.41% | Canaccord Genuity | Richard Close47% | $34 → $28 | Maintains | Buy | Get Alert |
11/17/2023 | Buy Now | 123.53% | JP Morgan | Lisa Gill59% | $33 → $19 | Maintains | Neutral | Get Alert |
10/25/2023 | Buy Now | 252.94% | RBC Capital | Sean Dodge48% | $35 → $30 | Maintains | Outperform | Get Alert |
10/25/2023 | Buy Now | 205.88% | Oppenheimer | Michael Wiederhorn61% | $35 → $26 | Maintains | Outperform | Get Alert |
10/23/2023 | Buy Now | 147.06% | Citigroup | Daniel Grosslight42% | $29 → $21 | Maintains | Neutral | Get Alert |
10/20/2023 | Buy Now | 147.06% | Citigroup | Daniel Grosslight42% | $29 → $21 | Maintains | Neutral | Get Alert |
09/25/2023 | Buy Now | 229.41% | Truist Securities | Jailendra Singh38% | → $28 | Reiterates | Hold → Hold | Get Alert |
07/26/2023 | Buy Now | 229.41% | Stephens & Co. | Jeff Garro37% | → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/26/2023 | Buy Now | 311.76% | RBC Capital | Sean Dodge48% | → $35 | Reiterates | Outperform → Outperform | Get Alert |
07/26/2023 | Buy Now | 241.18% | Citigroup | Daniel Grosslight42% | $31 → $29 | Maintains | Neutral | Get Alert |
07/26/2023 | Buy Now | 217.65% | Credit Suisse | Jonathan Yong64% | → $27 | Reiterates | Neutral → Neutral | Get Alert |
04/28/2023 | Buy Now | 241.18% | Deutsche Bank | George Hill62% | $27 → $29 | Maintains | Hold | Get Alert |
04/27/2023 | Buy Now | 264.71% | Citigroup | Daniel Grosslight42% | $30 → $31 | Maintains | Neutral | Get Alert |
04/27/2023 | Buy Now | 311.76% | RBC Capital | Sean Dodge48% | → $35 | Reiterates | → Outperform | Get Alert |
04/27/2023 | Buy Now | 217.65% | Credit Suisse | Jonathan Yong64% | → $27 | Reiterates | → Neutral | Get Alert |
04/27/2023 | Buy Now | 241.18% | Barclays | Steve Valiquette53% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
04/12/2023 | Buy Now | 194.12% | Stephens & Co. | Jeff Garro37% | → $25 | Initiates | → Equal-Weight | Get Alert |
03/10/2023 | Buy Now | 217.65% | Credit Suisse | Jonathan Yong64% | $30 → $27 | Maintains | Neutral | Get Alert |
03/06/2023 | Buy Now | 323.53% | Canaccord Genuity | Richard Close47% | $40 → $36 | Maintains | Buy | Get Alert |
03/06/2023 | Buy Now | 170.59% | Wells Fargo | Stan Berenshteyn42% | $28 → $23 | Maintains | Equal-Weight | Get Alert |
02/28/2023 | Buy Now | 252.94% | Citigroup | Daniel Grosslight42% | $33 → $30 | Maintains | Neutral | Get Alert |
02/27/2023 | Buy Now | 217.65% | Deutsche Bank | George Hill62% | $31 → $27 | Maintains | Hold | Get Alert |
02/27/2023 | Buy Now | 288.24% | JP Morgan | Lisa Gill59% | $35 → $33 | Maintains | Neutral | Get Alert |
02/23/2023 | Buy Now | 311.76% | Oppenheimer | Michael Wiederhorn61% | $37 → $35 | Maintains | Outperform | Get Alert |
02/23/2023 | Buy Now | 311.76% | RBC Capital | Sean Dodge48% | → $35 | Reiterates | → Outperform | Get Alert |
02/23/2023 | Buy Now | 300% | SVB Leerink | Stephanie Davis40% | → $34 | Upgrade | Market Perform → Outperform | Get Alert |
01/19/2023 | Buy Now | 335.29% | Oppenheimer | Colin Rusch55% | $45 → $37 | Maintains | Outperform | Get Alert |
01/18/2023 | Buy Now | 229.41% | Barclays | Marc Solecitto63% | $32 → $28 | Maintains | Equal-Weight | Get Alert |
12/13/2022 | Buy Now | 288.24% | Citigroup | Daniel Grosslight42% | $36 → $33 | Maintains | Neutral | Get Alert |
10/31/2022 | Buy Now | 252.94% | Credit Suisse | Jonathan Yong64% | $35 → $30 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | 323.53% | Citigroup | Daniel Grosslight42% | $38 → $36 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | 276.47% | Barclays | Steve Valiquette53% | $33 → $32 | Maintains | Equal-Weight | Get Alert |
10/25/2022 | Buy Now | 370.59% | DA Davidson | Robert Simmons54% | $45 → $40 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | — | Guggenheim | Sandy Draper72% | — | Upgrade | Sell → Neutral | Get Alert |
10/21/2022 | Buy Now | 241.18% | Truist Securities | Jailendra Singh38% | $35 → $29 | Maintains | Hold | Get Alert |
10/11/2022 | Buy Now | 288.24% | Barclays | Steve Valiquette53% | $40 → $33 | Maintains | Equal-Weight | Get Alert |
09/28/2022 | Buy Now | 311.76% | RBC Capital | Sean Dodge48% | $53 → $35 | Maintains | Outperform | Get Alert |
09/27/2022 | Buy Now | 264.71% | Deutsche Bank | George Hill62% | $34 → $31 | Maintains | Hold | Get Alert |
09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus44% | — | Initiates | → Sector Weight | Get Alert |
09/07/2022 | Buy Now | 311.76% | Truist Securities | Jailendra Singh38% | → $35 | Initiates | → Hold | Get Alert |
08/17/2022 | Buy Now | 194.12% | Guggenheim | Sandy Draper72% | → $25 | Downgrade | Neutral → Sell | Get Alert |
08/12/2022 | Buy Now | 429.41% | DA Davidson | Robert Simmons54% | → $45 | Initiates | → Buy | Get Alert |
08/02/2022 | Buy Now | 311.76% | Berenberg | Ravi Misra33% | $42 → $35 | Downgrade | Buy → Hold | Get Alert |
08/02/2022 | Buy Now | 300% | Cowen & Co. | Charles Rhyee37% | $58 → $34 | Downgrade | Outperform → Market Perform | Get Alert |
07/28/2022 | Buy Now | 323.53% | Goldman Sachs | Cindy Motz28% | $55 → $36 | Downgrade | Buy → Neutral | Get Alert |
07/28/2022 | Buy Now | 370.59% | Barclays | Steve Valiquette53% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
07/28/2022 | Buy Now | — | Needham | Ryan MacDonald60% | — | Downgrade | Buy → Hold | Get Alert |
07/28/2022 | Buy Now | 370.59% | Piper Sandler | Jessica Tassan40% | $42 → $40 | Maintains | Overweight | Get Alert |
07/28/2022 | Buy Now | 547.06% | Oppenheimer | Michael Wiederhorn61% | $65 → $55 | Maintains | Outperform | Get Alert |
The latest price target for Teladoc Health (NYSE:TDOC) was reported by Goldman Sachs on March 3, 2025. The analyst firm set a price target for $13.00 expecting TDOC to rise to within 12 months (a possible 52.94% upside). 43 analyst firms have reported ratings in the last year.
The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by Goldman Sachs, and Teladoc Health maintained their buy rating.
The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.
The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.
While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $16.00 to $13.00. The current price Teladoc Health (TDOC) is trading at is $8.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.